Senescence

From machines to animals to humans

Exclusive with Prof Joao Pedro de Magalhaes: talking AI, indication expansion and animal models. “Will you still need me, will you still feed me, when...

Some good news: announcing Longevity2020

In these challenging times, with everyone working from home and conferences pushed-back to later this year, we had an idea: Longevity2020 While the world overcomes...

The Reason behind Longevity: start-up opportunities

We connected with Reason (the person) to get the inside track on hot areas for Longevity R&D.   Longevity.Technology: Advocacy runs through Reason like a...

Anti-aging drugs in MIT’s 10 Breakthrough Technologies 2020

For the last 20 years MIT Technology Review's Breakthrough Technologies 2020 has been assessing the way we live, work and invest.  Back in 2001, MIT...

Pathway to Longevity: get rid of zombie cells

Understanding the trigger for cellular senescence could help to forge new treatments for Longevity, stopping aging before it's started. Cellular senescence is a double-edged sword;...

Biosens raising £5m to support commercialisation

Start-up targets cell senescence therapies and near-term opportunities in advanced cosmetics market. The market for the development of anti-senescence therapeutics is on fire and we’ve...

Five Alarm Bio targets Alzheimer’s and skin aging

Stealthy anti-aging start-up kicks-off £2.6m fundraise to target both Alzheimer's and advanced cosmetics. Many of the companies working in the Longevity sector are playing their...

Next generation of senescence research

Teenage founder of Canadian start-up Biotein hunts a universal phenotype for senescent cells. Nina Khera (pictured above, first left) became interested in the challenge of...

Chinese medicine plant activates telomerase

A new study shows that certain nutrients and natural compounds can act as potent telomerase activators has implications for Longevity and the development of...

Cellular senescence: a precise biomarker in humans?

A world-first study shows that even though senescence is a key hallmark of chronological aging in humans, senescence levels may vary significantly between organs...

2020 outlook for Longevity technology

Will 2020 be the year that sees a step change in Longevity? We review technology readiness levels for key Longevity domains. Yep, we have a...

Senescence market set to hit $644m by 2023

The global longevity and anti-senescence therapies market is set to grow to $644.4 million by 2023. According to a report from Trends Market Research (published...

Exclusive interview: The dynamics of telomeres

Can biological markers predict brain age? From measuring telomeres to computational approaches, promising research is beginning to find out just how it can be...

Correlation between telomere length and brain age

A study by researchers at the Max Planck Institute for Human Cognitive and Brain Sciences has shown that when telomeres change in length, changes...

Pay-to-play age reduction has $1m price tag

This is the world's first IRB-approved clinical trial aimed at reversing aging by at least 20 years; it is also the world's most expensive...

Exclusive interview: A new generation of senolytic

When is a drug not a drug? When it's a NaNot. Interesting new technology that's already on its way through FDA and targeting $40m Series...

Senescence biomarkers identified and publicly shared

New research proposes how to use ICSA consensus as a guideline for senescence biomarkers. Since their discovery 60 years ago, significant progress has been made...

Telomeres extend lifespan without genetic mods

The Spanish National Cancer Research Centre (CNIO) have discovered a way for telomeres to extend the lifespan of mice without genetic modification. Scientists have been...

60 new Biotech and Agetech start-ups to join showcase

Applications open for the Longevity Leaders World Congress start-up showcase. The Longevity sector is in part characterised by the emergence of two exciting classes of...

Telomere shortening tied to structural changes in the brain

Max Planck researchers find changes across mere months, that are possibly reversed by brain training by telomore shortening.  The tips of our chromosomes, known as...

Latest articles

COVID-19: Leading clinician calls for focus on the biology of aging

Dr Nir Barzilai predicts that rapamycin could decrease severity of coronavirus in the elderly by 50%. When it comes to the world of Longevity and...

Global investment consortium slated to back Telocyte into Phase 1

Telomerase therapy ready for human Alzheimer’s trials. “There have been more than 400 registered trials for Alzheimer's and, by global consensus, every single one has...

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Telomeres on repeat to inhibit inflamm-aging

Coming around again – Italian team hopes to use repeated nucleobases to delay aging through extending telomeres. Inflammation is a double-edged sword; while it is necessary...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.